Related Experiment Videos
Fast magnetic resonance imaging with contrast for soft tissue sarcoma viability
Lorraine G Shapeero1, Daniel Vanel, Koenraad L Verstraete
1Department of Radiology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4799, USA.
Clinical Orthopaedics and Related Research
|April 16, 2002
Summary
Dynamic contrast-enhanced MRI precisely identifies viable soft tissue sarcoma for biopsies and treatment response. This advanced imaging technique aids in differentiating tumor recurrence from inflammation, improving patient management.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Soft tissue sarcomas require accurate assessment of tumor viability.
- Conventional MRI sequences have limitations in evaluating tumor kinetics.
Purpose of the Study:
- To evaluate the efficacy of dynamic contrast-enhanced MRI (DCE-MRI) in soft tissue sarcomas.
- To assess DCE-MRI for biopsy localization, chemotherapy response, and recurrence detection.
Main Methods:
- Patients underwent conventional MRI followed by dynamic contrast-enhanced MRI with fast/ultrafast sequences.
- Postprocessing included subtraction, time-intensity curves, and parametric color-encoding.
- Study applications included biopsy guidance, chemotherapy response assessment, and differentiating recurrence from inflammation.
Main Results:
- DCE-MRI improved biopsy site selection in 10 of 40 patients.
- DCE-MRI distinguished chemotherapy responders from non-responders.
- DCE-MRI detected early tumor recurrence and differentiated it from post-treatment inflammation.
Conclusions:
- Dynamic contrast-enhanced MRI effectively defines viable tumor in soft tissue sarcomas.
- DCE-MRI assists in biopsy localization, assessing treatment efficacy, and detecting recurrence.
- This imaging modality impacts initial evaluation, treatment, and follow-up of soft tissue sarcoma patients.